Alnylam Pharmaceuticals | ALNY - Pre Tax Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals reported $-172362000 in Pre-Tax Profit for its fiscal quarter ending in March of 2023.


Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -44939000 4.05M
Agios Pharmaceuticals AGIO:US USD -81018000 117.54M
Alnylam Pharmaceuticals ALNY:US USD -172362000 34.66M
Arrowhead Research ARWR:US USD 47.68M 89.47M
Bluebird Bio BLUE:US USD 21.24M 11.1M
Intercept Pharmaceuticals ICPT:US USD -31881000 14.34M
Ionis Pharmaceuticals IONS:US USD -113000000 81M
Mirati Therapeutics MRTX:US USD -184586000 17.63M
Neurocrine Biosciences NBIX:US USD -103300000 221.2M
PTC Therapeutics PTCT:US USD -134990000 21.32M
Regulus Therapeutics RGLS:US USD -7139000 344K
Sangamo BioSciences SGMO:US USD 21.33M 73.04M
Sarepta Therapeutics SRPT:US USD -512710000 411.4M
Takeda 4502:JP JPY 47.92B 59.24B
Ultragenyx Pharmaceutical RARE:US USD -163477000 10.19M
Xencor XNCR:US USD -60763000 48.31M